Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: Radiation oncology report of the Department of Defense Center for Prostate Disease Research

Radiology

Volumn 225, Issue 2, 2002, Pages 420-426

  Johnstone, Peter A S ^a   Kane, Christopher J ^a   Sun, Leon ^a   Wu, Hongyu ^a   Moul, Judd W ^a   McLeod, David G ^a   Martin, Douglas D ^a   Kusuda, Leo ^a   Lance, Raymond ^a   Douglas, Robert ^a   Donahue, Timothy ^a   Beat, Michael G ^a   Foley, John ^a   Baldwin, Dalton ^a   Soderdahl, Douglas ^a   Do, Jason ^a   Amling, Christopher L ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Data analysis; Prostate neoplasms; Prostate neoplasms, therapeutic radiology

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEGRO; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RACE DIFFERENCE; RADIATION DOSE; STATISTICAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0036829399     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2252011491     Document Type: Article

References (37)

1. Greenlee RT, Murray T, Bolden S, Wingo WA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50:7-33.
2. Natarajan N, Murphy GP, Mettlin C. Prostate cancer in blacks: An update from the American College of Surgeons patterns of care studies. J Surg Oncol 1989; 40:232-236.
3. Mettlin CJ, Murphy GP, McGinnis LS, et al. The National Cancer Data Base report on prostate cancer: American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1995; 76:1104-1112.
4. Powell IJ, Heilbrun LK, Sakr W, et al. The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: A multivariate analysis of positive surgical margins. Urology 1997; 49:726-731.
5. Zeitman A, Moughan J, Owen J, Hanks G. The patterns of care survey of radiation therapy in localized prostate cancer: Similarities between the practice nationally and in minority-rich areas. Int J Radiat Oncol Biol Phys 2001; 50:75-80.
6. Mettlin CJ, Murphy GP, Cunningham MP, Menck HP. The National Cancer Data Base report on race, age, and region variation in prostate cancer treatment. Cancer 1997; 80:1261-1266.
7. Hussain F, Aziz H, Macchia R, Avitable M, Rotman M. High grade adenocarcinoma of prostate in smokers of ethnic minority groups and Caribbean island immigrants. Int J Radiat Oncol Biol Phys 1992; 24:451-461.
8. Teshima T, Hanlon AM, Hanks GE. Pre-treatment prostate-specific antigen values in patients with prostate cancer: 1989 Patterns of care study process survey. Int J Radiat Oncol Biol Phys 1995; 33:809-814.
9. Moul JW, Sesterhenn IA, Connelly RR, et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA 1995; 274:1277-1281.
10. Vijayakumar S, Weichselbaum R, Vaida F, et al. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status. Cancer J Sci Am 1996; 2:225-233.
11. Mebane C, Gibbs T, Horm J. Current status of prostate cancer in North American black males. J Natl Med Assoc 1990; 82:782-788.
12. Chuba PJ, Moughan J, Forman JD, Owen J, Hanks G. The 1989 patterns of care study for prostate cancer: Five-year outcomes. Int J Radiat Oncol Biol Phys 2001; 50:325-334.
13. Blair A, Fraumeni JF. Geographic patterns of prostate cancer in the United States. J Natl Cancer Inst 1978; 61:1379-1384.
14. Pienta KJ, Demers R, Hoff M, et al. Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tricounty area, 1973 to 1987. Urology 1995; 45:93-101.
15. Morris CR, Snipes KP, Schlag R, Wright WE. Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States). Cancer Causes Control 1999; 10:503-511.
16. Alexander GA, Brawley OW. Prostate cancer treatment outcome in blacks and whites: A summary of the literature. Semin Urol Oncol 1998; 16:232-234.
17. Austin JP, Convery K. Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation. Am J Clin Oncol 1993; 16:140-145.
18. Barroso U, Oskanian P, Tefilli MV, et al. Population-based study of pelvic lymph node postitivity in clinically localized prostate cancer: A study comparing African-Americans and whites. Urology 1999; 53:187-191.
19. Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA 1995; 274:1599-1605.
20. Moul JW, Douglas TH, McCarthy WF, McLeod DG. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care system. J Urol 1996; 155:1667-1673.
21. Tarman GJ, Kane CJ, Moul JW, et al. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. J Urol 2000; 56:1016-1020.
22. Kim JA, Kuban DA, el-Mahdi AM, Schellhammer PF. Carcinoma of the prostate: Race as a prognostic factor in definitive radiation therapy. Radiology 1995; 194:545-549.
23. Roach MD, Krall J, Keller JW, et al. The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985). Int J Radiat Oncol Biol Phys 1992; 24:441-449.
24. Iselin CE, Box JW, Vollmer RT, et al. Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males. Cancer 1998; 83:2353-2360.
25. Hart KB, Porter AT, Shamsa F, et al. The influence of race on the efficacy of curative radiation therapy for carcinoma of the prostate. Semin Urol Oncol 1998; 16:227-231.
26. Zagars GK, Pollack A, Pettaway CA. Prostate cancer in African-American men: Outcome following radiation therapy with or without adjuvant androgen deprivation. Int J Radiat Oncol Biol Phys 1998; 42:517-523.
27. Sohayda CJ, Kupelian PA, Altsman KA, Klein EA. Race as an independent predictor of outcome after localized treatment for localized prostate cancer. J Urol 1999; 162:1331-1336.
28. Connell PP, Ignacio L, Haraf D, et al. Equivalent racial outcome after conformal radiotherapy for prostate cancer: A single departmental experience. J Clin Oncol 2001; 19:54-61.
29. Preston DM, Bauer JJ, Connelly RR, et al. Prostate-specific antigen to predict outcome of external beam radiation for prostate cancer: The Walter Reed Army Medical Center experience, 1988-1995. Urology 1999; 53:131-138.
30. Powell C, Huisman T, Riffenburgh R, Saunders EL, Bethel KJ, Johnstone PAS. Outcome for surgically staged localized prostate cancer treated with external beam radiation therapy. J Urol 1997; 157:1754-1759.
31. Gray CL, Powell CR, Riffenburgh RH, Johnstone PAS. 20 Year outcome for patients with T1-3N0 surgically staged prostate cancer treated with external beam radiation therapy. J Urol 2001; 166:116-118.
32. Johnstone PAS, Gray C, Powell CR. Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up. Int J Radiat Oncol Biol Phys 2000; 46:833-838.
33. American Society for Therapeutic Radiology and Oncology Consensus Panel. Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37:1035-1041.
34. Horner RD. Racial variation in cancer care: A case study of prostate cancer. Cancer Treat Res 1998; 97:99-114.
35. Harlan L, Brawley O, Pommerenke F, Wali P, Kramer B. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol 1995; 13:93-100.
36. Bibb SC. Access and late-stage diagnosis of breast cancer in the military health care system. Mil Med 2000; 165:585-590.
37. Farley JH, Hines JF, Taylor RR, et al. Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer 2001; 91:869-873.